Ada göre bir ilaç arayın

Trimipramine Maleate ve Kalp-damar hastalığı

Trimipramine Maleate ilacının Kalp-damar hastalığı hastalığı ile etkileşiminin güvenlik kontrolünün sonucu.

Kontrolün sonucu:

Trimipramine Maleate <> Kalp-damar hastalığı

Güncellik: 23.07.2019 Eleştirmen: MD PHD P.M. Shkutko, in

Drugs.com, Rxlist.com, Webmd.com, Medscape.com gibi yetkili kaynaklara dayalı kontrolün sonucunda bu ilacın bu komorbid hastalık ile etkileşmesi halinde zarar verebilen veya olumsuz etkisini artırabilen kontrendikasyonlar veya yan etkiler bulundu.

Tüketici:

(TSA): trisiklik antidepresanlar ve tetrasiklik i özellikle tedavi veya doz hızla artması başlangıcında ortostatik hipotansiyon, refleks taşikardi, senkop ve baş dönmesi neden olabilir. Alternatifler böyle nortriptilin gibi sekonder Amin daha az sıklıkta bunu yapmak olsa da bu etkilere neden büyük bir eğilimi var görünüyor. Hipotansif etkilerine karşı tolerans genellikle birkaç hafta birkaç doz sonra gelişir. Nadiren, çöküntü ve ani ölüm şiddetli hipotansiyona sekonder olarak meydana gelmiştir. Diğer bildirilen yan etkileri kardiyovasküler gibi PR ve QT uzaması gibi taşikardi, aritmi, kalp bloğu, hipertansiyon, tromboz, tromboflebit, miyokard infarktüsü, inme, konjestif kalp yetmezliği ve EKG anormallikleri vardır. TSA ile tedavi akut miyokard enfarktüsü sonrası iyileşme döneminde kaçınılmalıdır, ve sadece çok dikkatli hipertiroidi, kardiyovasküler veya serebrovasküler hastalığı, hipotansiyon ya da bir yatkınlık olan hastalarda uygulanmalıdır. Kardiyovasküler durumunu yakından izleme, EKG değişiklikleri de dahil olmak üzere, tüm dozlarda önerilir. Daha yeni antidepresanların birçok bupropion (SSRI), selektif serotonin geri alım inhibitörleri dahil olmak üzere, kardiyotoksik daha az veya minimal ve uygun bir alternatif olabilir.

Kaynaklar

"Product Information. Tofranil (imipramine)." Novartis Pharmaceuticals, East Hanover, NJ.
Gross JS, Zwerin G "Left bundle branch block developing in a patient with sub-therapeutic nortriptyline levels: a case report." J Am Geriatr Soc 39 (1991): 1006-7
Appelbaum PS, Kapoor W "Imipramine-induced vasospasm: a case report." Am J Psychiatry 140 (1983): 913-5
"Product Information. Anafranil (clomipramine)." Basel Pharmaceuticals, Summit, NJ.
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM "Pharmacotherapy: A Pathophysiologic Approach 4th" Stamford, CT: Appleton & Lange (1999):
"Product Information. Ludiomil (maprotiline)." Ciba-Geigy Pharmaceuticals, East Hanover, NJ.
Christensen P, Thomsen HY, Pedersen OL, et al "Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients." Psychopharmacology (Berl) 87 (1985): 212-5
"Product Information. Surmontil (trimipramine)" Wyeth-Ayerst Laboratories, Philadelphia, PA.
Kantor SJ, Glassman AH, Bigger JT, Jr Perel JM, Giardina EV "The cardiac effects of therapeutic plasma concentrations of imipramine." Am J Psychiatry 135 (1978): 534-8
Rudorfer MV, Young RC "Desipramine: cardiovascular effects and plasma levels." Am J Psychiatry 137 (1980): 984-6
"Product Information. Norpramin (desipramine)." Hoechst Marion-Roussel Inc, Kansas City, MO.
Burrows GD, Vohra J, Hunt D, Sloman JG, Scoggins BA, Davies B "Cardiac effects of different tricyclic antidepressant drugs." Br J Psychiatry 129 (1976): 335-41
Robinson DS, Nies A, Corcella J, Cooper TB, Spencer C, Kefover R "Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients." J Clin Psychiatry 43 (1982): 8-15
Georgotas A, McCue RE, Hapworth W, et al "Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly." Biol Psychiatry 21 (1986): 1155-66
Feighner JP, Cohn JB, Fabre LF, Jr Fieve RR, Mendels J, Shrivastava RK, Dunbar GC "A study comparing paroxetine placebo and imipramine in depressed patients." J Affect Disord 28 (1993): 71-9
Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG "Is doxepin a safer tricyclic for the heart?" J Clin Psychiatry 52 (1991): 338-41
"Product Information. Asendin (amoxapine)" Lederle Laboratories, Wayne, NJ.
"Product Information. Pamelor (nortriptyline)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30
Pedersen JH, Sorensen JL "Therapeutic effect and side effects in patients with endogenous depression treated with oral nortriptyline once a day." Neuropsychobiology 6 (1980): 42-7
Roose SP, Glassman AH, Siris SG, Walsh BT, Bruno RL, Wright LB "Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference." J Clin Psychopharmacol 1 (1981): 316-9
Nelson JC, Jatlow PI, Bock J, Quinlan DM, Bowes MB "Major adverse reactions during desipramine treatment." Arch Gen Psychiatry 39 (1982): 1055-61
Luchins DJ "Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants." Am J Psychiatry 140 (1983): 1006-9
"Product Information. Sinequan (doxepin)." Roerig Division, New York, NY.
Van Sweden B "Rebound antidepressant cardiac arrhythmia." Biol Psychiatry 24 (1988): 363-4
Laird LK, Lydiard RB, Morton WA, Steele TE, Kellner C, Thompson NM, Ballenger JC "Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients." J Clin Psychiatry 54 (1993): 224-8
Young RC, Alexopoulos GS, Shamoian CA, Dhar AK, Kutt H "Heart failure associated with high plasma 10-hydroxynortriptyline levels." Am J Psychiatry 141 (1984): 432-3
Veith RC, Bloom V, Bielski R, Friedel RO "ECG effects of comparable plasma concentrations of desipramine and amitriptyline." J Clin Psychopharmacol 2 (1982): 394-8
Roos JC "Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine." Br J Clin Pharmacol 15 Suppl 3 (1983): s439-45
Faravelli C, Brat A, Marchetti G, Franchi F, Padeletti L, Michelucci A, Pastorino A "Cardiac effects of clomipramine treatment. ECG and left ventricular systolic time intervals." Neuropsychobiology 9 (1983): 113-8
Carpenter P, Gobel FL, Hulsing DJ "Desipramine cardiac toxicity." Minn Med 65 (1982): 231-4
Ramanathan KB, Davidson C "Cardiac arrhythmia and imipramine therapy." Br Med J 1 (1975): 661-2
Bluhm RE, Wilkinson GR, Shelton R, Branch RA "Genetically determined drug-metabolizing activity and desipramine- associated cardiotoxicity: a case report." Clin Pharmacol Ther 53 (1993): 89-95
"Product Information. Elavil (amitriptyline)." Stuart Pharmaceuticals, Wilmington, DE.
Dunn FG "Malignant hypertension associated with use of amitriptyline hydrochloride." South Med J 75 (1982): 1124-5
"Product Information. Vivactil (protriptyline)" Merck & Co, Inc, West Point, PA.
Strasberg B, Coelho A, Welch W, Swiryn S, Bauernfeind R, Rosen K "Doxepin induced torsade de pointes." Pacing Clin Electrophysiol 5 (1982): 873-7
Linnoila M, Jobson KO, Gilliam JH, Paine RL "Effects of doxepin on blood pressure and heart rate in patients with primary major affective disorder ." J Clin Psychopharmacol 2 (1982): 433-4

Trimipramine Maleate

Jenerik adı: trimipramine

Marka adı: Surmontil

Eşdeğer ilaçlar: Trimipramine

Trimipramine Maleate nedir?

Diğer ilaç Sil